BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

366 related articles for article (PubMed ID: 37252095)

  • 21. Pyrimidine: An elite heterocyclic leitmotif in drug discovery-synthesis and biological activity.
    Nadar S; Khan T
    Chem Biol Drug Des; 2022 Dec; 100(6):818-842. PubMed ID: 34914188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Application and synthesis of thiazole ring in clinically approved drugs.
    Niu ZX; Wang YT; Zhang SN; Li Y; Chen XB; Wang SQ; Liu HM
    Eur J Med Chem; 2023 Mar; 250():115172. PubMed ID: 36758304
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A Comprehensive Review on Journey of Pyrrole Scaffold Against Multiple Therapeutic Targets.
    Mir RH; Mir PA; Mohi-Ud-Din R; Sabreen S; Maqbool M; Shah AJ; Shenmar K; Raza SN; Pottoo FH
    Anticancer Agents Med Chem; 2022; 22(19):3291-3303. PubMed ID: 35702764
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Promising in vitro and in vivo inhibition of multidrug-resistant Helicobacter pylori by linezolid and novel oxazolidinone analogues.
    Shi J; Jiang Y; Zhao Y
    J Glob Antimicrob Resist; 2016 Dec; 7():106-109. PubMed ID: 27718441
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The discovery of linezolid, the first oxazolidinone antibacterial agent.
    Ford CW; Zurenko GE; Barbachyn MR
    Curr Drug Targets Infect Disord; 2001 Aug; 1(2):181-99. PubMed ID: 12455414
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Drug-drug interactions and safety of linezolid, tedizolid, and other oxazolidinones.
    Douros A; Grabowski K; Stahlmann R
    Expert Opin Drug Metab Toxicol; 2015; 11(12):1849-59. PubMed ID: 26457865
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Synthesis and Biological Evaluation of the Antimicrobial Natural Product Lipoxazolidinone A.
    Mills JJ; Robinson KR; Zehnder TE; Pierce JG
    Angew Chem Int Ed Engl; 2018 Jul; 57(28):8682-8686. PubMed ID: 29845720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis of novel oxazolidinone antimicrobial agents.
    Ebner DC; Culhane JC; Winkelman TN; Haustein MD; Ditty JL; Ippoliti JT
    Bioorg Med Chem; 2008 Mar; 16(5):2651-6. PubMed ID: 18077175
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New potent antibacterial oxazolidinone (MRX-I) with an improved class safety profile.
    Gordeev MF; Yuan ZY
    J Med Chem; 2014 Jun; 57(11):4487-97. PubMed ID: 24694071
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 1,3-Diazepine: A privileged scaffold in medicinal chemistry.
    Malki Y; Martinez J; Masurier N
    Med Res Rev; 2021 Jul; 41(4):2247-2315. PubMed ID: 33645848
    [TBL] [Abstract][Full Text] [Related]  

  • 31. An Overview of the Pharmacological Activities and Synthesis of Benzothiophene Derivatives.
    Pathak S; Pratap Singh A; Sharma R; Pandey R
    Med Chem; 2024 Jun; ():. PubMed ID: 38920062
    [TBL] [Abstract][Full Text] [Related]  

  • 32. 1,3,4-Thiadiazole: A Versatile Pharmacophore of Medicinal Significance.
    Bala M; Piplani P; Ankalgi A; Jain A; Chandel L
    Med Chem; 2023; 19(8):730-756. PubMed ID: 36593699
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tedizolid: a novel oxazolidinone with potent activity against multidrug-resistant gram-positive pathogens.
    Zhanel GG; Love R; Adam H; Golden A; Zelenitsky S; Schweizer F; Gorityala B; Lagacé-Wiens PR; Rubinstein E; Walkty A; Gin AS; Gilmour M; Hoban DJ; Lynch JP; Karlowsky JA
    Drugs; 2015 Feb; 75(3):253-70. PubMed ID: 25673021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oxadiazole: A highly versatile scaffold in drug discovery.
    Desai N; Monapara J; Jethawa A; Khedkar V; Shingate B
    Arch Pharm (Weinheim); 2022 Sep; 355(9):e2200123. PubMed ID: 35575467
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bioactive pyrrole-based compounds with target selectivity.
    Li Petri G; Spanò V; Spatola R; Holl R; Raimondi MV; Barraja P; Montalbano A
    Eur J Med Chem; 2020 Dec; 208():112783. PubMed ID: 32916311
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promising antituberculosis activity of the oxazolidinone PNU-100480 relative to that of linezolid in a murine model.
    Williams KN; Stover CK; Zhu T; Tasneen R; Tyagi S; Grosset JH; Nuermberger E
    Antimicrob Agents Chemother; 2009 Apr; 53(4):1314-9. PubMed ID: 19075058
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Syntheses and medicinal chemistry of azepinoindolones: a look back to leap forward.
    Kadagathur M; Patra S; Sigalapalli DK; Shankaraiah N; Tangellamudi ND
    Org Biomol Chem; 2021 Jan; 19(4):738-764. PubMed ID: 33459333
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Novel promising linezolid analogues: rational design, synthesis and biological evaluation.
    De Rosa M; Zanfardino A; Notomista E; Wichelhaus TA; Saturnino C; Varcamonti M; Soriente A
    Eur J Med Chem; 2013 Nov; 69():779-85. PubMed ID: 24099997
    [TBL] [Abstract][Full Text] [Related]  

  • 39. In search of uracil derivatives as bioactive agents. Uracils and fused uracils: Synthesis, biological activity and applications.
    Pałasz A; Cież D
    Eur J Med Chem; 2015 Jun; 97():582-611. PubMed ID: 25306174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Synthesis, SAR, and antibacterial activity of novel oxazolidinone analogues possessing urea functionality.
    Selvakumar N; Rajulu GG; Reddy KC; Chary BC; Kumar PK; Madhavi T; Praveena K; Reddy KH; Takhi M; Mallick A; Amarnath PV; Kandepu S; Iqbal J
    Bioorg Med Chem Lett; 2008 Jan; 18(2):856-60. PubMed ID: 18155521
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.